Skip to content

Effect evaluation of Oncokompas 2.0.

Efficacy and cost-utility of Oncokompas 2.0, a self-management eHealth application for cancer survivors.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28918
Enrollment
544
Registered
2016-03-08
Start date
2016-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, cancer survivors Kanker

Interventions

Access to Oncokompas 2.0.

Sponsors

Vrije Universiteit Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with breast, colorectal, head and neck cancer or lymphoma, age ≥ 18 years (no upper limit), 3 months – 5 years after treatment with curative intent (all treatment modalities) and with accessibility to the internet.

Exclusion criteria

Exclusion criteria: Severe cognitive impairment, insufficient mastery of Dutch language, or insufficient basic internet skills.

Design outcomes

Primary

MeasureTime frame
Patient Activation Measure (PAM)

Secondary

MeasureTime frame
Self efficacy, patient empowerment, need for supportive care, mental adjustment to cancer, health related QoL, costs

Contacts

Public ContactAnja van der Hout

Van der Boechorstraat 1

a.vander.hout@vu.nl+31(0)20-5987451

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)